Dr Calvin Stiller

Guest Contributor
January 24, 2006

Dr Calvin Stiller and Dr Ronald Cresswell have appointed to the board of directors of Vasogen Inc, a Toronto-based developer of technologies targetting inflammation related to cardiovascular and neurological diseases. Stiller has a strong medical and venture capital background, while Cresswell is a veteran executive of several multinational pharmaceuti


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.